Back to Search Start Over

Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.

Authors :
Mole DJ
Fallowfield JA
Sherif AE
Kendall T
Semple S
Kelly M
Ridgway G
Connell JJ
McGonigle J
Banerjee R
Brady JM
Zheng X
Hughes M
Neyton L
McClintock J
Tucker G
Nailon H
Patel D
Wackett A
Steven M
Welsh F
Rees M
Source :
PloS one [PLoS One] 2020 Dec 02; Vol. 15 (12), pp. e0238568. Date of Electronic Publication: 2020 Dec 02 (Print Publication: 2020).
Publication Year :
2020

Abstract

The risk of poor post-operative outcome and the benefits of surgical resection as a curative therapy require careful assessment by the clinical care team for patients with primary and secondary liver cancer. Advances in surgical techniques have improved patient outcomes but identifying which individual patients are at greatest risk of poor post-operative liver performance remains a challenge. Here we report results from a multicentre observational clinical trial (ClinicalTrials.gov NCT03213314) which aimed to inform personalised pre-operative risk assessment in liver cancer surgery by evaluating liver health using quantitative multiparametric magnetic resonance imaging (MRI). We combined estimation of future liver remnant (FLR) volume with corrected T1 (cT1) of the liver parenchyma as a representation of liver health in 143 patients prior to treatment. Patients with an elevated preoperative liver cT1, indicative of fibroinflammation, had a longer post-operative hospital stay compared to those with a cT1 within the normal range (6.5 vs 5 days; p = 0.0053). A composite score combining FLR and cT1 predicted poor liver performance in the 5 days immediately following surgery (AUROC = 0.78). Furthermore, this composite score correlated with the regenerative performance of the liver in the 3 months following resection. This study highlights the utility of quantitative MRI for identifying patients at increased risk of poor post-operative liver performance and a longer stay in hospital. This approach has the potential to inform the assessment of individualised patient risk as part of the clinical decision-making process for liver cancer surgery.<br />Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: MK, GR, JJC, JMcG, RB, and JMB are employees and shareholders at Perspectum Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no other actual or perceived conflicts of interest to declare.

Details

Language :
English
ISSN :
1932-6203
Volume :
15
Issue :
12
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
33264327
Full Text :
https://doi.org/10.1371/journal.pone.0238568